drugset / Trial / NCT05008965
Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma.
Timeline
- Start
- 2021-07-27
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FB825 | Unknown | 4 mg/kg | Intravenous |